Atlas Trials

Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia

Clinical trial NCT04753476 · UNKNOWN

Trial details

NCT number
NCT04753476
Sponsor
Stem Cell and Cancer Research Indonesia
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Covid-19Cytokine Storm
Start date
2020-06-08
Primary completion
2022-02-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.